COVID - International Biopharmaceutical Industry

news

J&J cuts COVID vaccine sales forecasts, citing high supplies and lagging demand

Dive Brief: Johnson & Johnson is lowering its forecast for COVID-19 vaccine sales, announcing Tuesday it will has suspended its guidance of $3 billion to $3.5 ...

25 April 2022 news billion | COVID

Continue Reading →

news

Adagio plans comeback for COVID drug, but is it too late?

Dive Brief: Adagio Therapeutics said it will ask the Food and Drug Administration for emergency authorization of its COVID-19 drug after announcing Wednesday that ...

1 April 2022 news Adagio | adintrevimab

Continue Reading →

news

Alnylam sues Pfizer, Moderna over technology used in COVID vaccines

Dive Brief: Alnylam is accusing Pfizer and Moderna of violating a patent it holds for technology that Alnylam claims the two companies use in their respective COVI...

21 March 2022 news Alnylam | COVID

Continue Reading →

news

Adagio pledges to press forward with COVID drug as CEO to resign

Dive Brief: Adagio Therapeutics CEO Tillman Gerngross has agreed "in principle" to resign as head of the COVID-19 drug developer amid confusion over whether its mo...

24 February 2022 news Adagio | Adimab

Continue Reading →

news

Lilly drug becomes first COVID antibody cleared for use in young children

When bamlanivimab gained initial authorization 13 months ago, it was the first drug specifically designed to arrest infections of the SARS-CoV-2 virus that causes COV...

10 December 2021 news bamlanivimab | COVID

Continue Reading →